Literature DB >> 29425318

Albumin downregulates Klotho in tubular cells.

Beatriz Fernandez-Fernandez1,2,3, M Concepcion Izquierdo1,2,3, Lara Valiño-Rivas1,2,3, Dimitra Nastou4, Ana B Sanz1,2,3, Alberto Ortiz1,3, Maria D Sanchez-Niño1,2,3.   

Abstract

Background: Kidney tubular cells are the main sources of Klotho, a protein with phosphaturic action. Genetic Klotho deficiency causes premature cardiovascular aging in mice. Human chronic kidney disease (CKD) is characterized by acquired Klotho deficiency. Despite the lack of uremic toxin accumulation, Category G1 CKD [(normal glomerular filtration rate (GFR)] is already associated with decreased Klotho and with premature cardiovascular aging.
Methods: We have explored whether albuminuria, a criterion to diagnose CKD when GFR is normal, may directly decrease Klotho expression in human CKD, preclinical models and cultured tubular cells.
Results: In a CKD cohort, albuminuria correlated with serum phosphate after adjustment for GFR, age and sex. In this regard, urinary Klotho was decreased in patients with pathological albuminuria but preserved GFR. Proteinuria induced in rats by puromycin aminonucleoside and in mice by albumin overload was associated with interstitial inflammation and reduced total kidney Klotho messenger ribonucleic acid (mRNA) expression. Western blot disclosed reduced kidney Klotho protein in proteinuric rats and mice and immunohistochemistry localized the reduced kidney Klotho expression to tubular cells in proteinuric animals. In cultured murine and human tubular cells, albumin directly decreased Klotho mRNA and protein expression. This was inhibited by trichostatin A, an inhibitor of histone deacetylases, but unlike cytokine-induced Klotho downregulation, not by inhibitors of nuclear factor kappa-light-chain-enhancer of activated B cells. Conclusions: In conclusion, albumin directly decreases Klotho expression in cultured tubular cells. This may explain, or at least contribute to, the decrease in Klotho and promote fibroblast growth factor 23 resistance in early CKD categories, as observed in preclinical and clinical proteinuric kidney disease.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29425318     DOI: 10.1093/ndt/gfx376

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  26 in total

Review 1.  Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease.

Authors:  Mehmet Kanbay; Mustafa C Bulbul; Sidar Copur; Baris Afsar; Alan A Sag; Dimitrie Siriopol; Masanari Kuwabara; Silvia Badarau; Adrian Covic; Alberto Ortiz
Journal:  J Nephrol       Date:  2020-05-21       Impact factor: 3.902

2.  CKD: The burden of disease invisible to research funders.

Authors: 
Journal:  Nefrologia (Engl Ed)       Date:  2022 Jan-Feb

3.  Serum Klotho levels in primary hyperparathyroidism patients before and after parathyroidectomy.

Authors:  Chi Su; Lingqiong Meng; Stanley Z Trooskin; Sue A Shapses; Yuling He; Aseel Al-Dayyeni; Xiangbing Wang
Journal:  Endocrine       Date:  2020-07-24       Impact factor: 3.633

Review 4.  Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease.

Authors:  Julio M Martinez-Moreno; Miguel Fontecha-Barriuso; Diego Martin-Sanchez; Juan Guerrero-Mauvecin; Elena Goma-Garces; Beatriz Fernandez-Fernandez; Sol Carriazo; Maria D Sanchez-Niño; Adrian M Ramos; Marta Ruiz-Ortega; Alberto Ortiz; Ana B Sanz
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

5.  Mediation of the relationship between proteinuria and serum phosphate: Insight from the KNOW-CKD study.

Authors:  Ji Yong Jung; Han Ro; Jae Hyun Chang; Ae Jin Kim; Hyun Hee Lee; Seung Hyeok Han; Tae-Hyun Yoo; Kyu-Beck Lee; Yeong Hoon Kim; Soo Wan Kim; Sue Kyung Park; Dong-Wan Chae; Kook-Hwan Oh; Curie Ahn; Wookyung Chung
Journal:  PLoS One       Date:  2020-06-22       Impact factor: 3.240

Review 6.  Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.

Authors:  Esmeralda Castillo-Rodriguez; Raul Fernandez-Prado; Raquel Esteras; Maria Vanessa Perez-Gomez; Carolina Gracia-Iguacel; Beatriz Fernandez-Fernandez; Mehmet Kanbay; Alberto Tejedor; Alberto Lazaro; Marta Ruiz-Ortega; Emilio Gonzalez-Parra; Ana B Sanz; Alberto Ortiz; Maria Dolores Sanchez-Niño
Journal:  Toxins (Basel)       Date:  2018-07-19       Impact factor: 4.546

Review 7.  Chronodisruption: A Poorly Recognized Feature of CKD.

Authors:  Sol Carriazo; Adrián M Ramos; Ana B Sanz; Maria Dolores Sanchez-Niño; Mehmet Kanbay; Alberto Ortiz
Journal:  Toxins (Basel)       Date:  2020-02-28       Impact factor: 4.546

Review 8.  Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease.

Authors:  Juan Rafael Muñoz-Castañeda; Cristian Rodelo-Haad; Maria Victoria Pendon-Ruiz de Mier; Alejandro Martin-Malo; Rafael Santamaria; Mariano Rodriguez
Journal:  Toxins (Basel)       Date:  2020-03-16       Impact factor: 4.546

9.  Klotho, the elusive kidney-derived anti-ageing factor.

Authors:  Maria Dolores Sanchez-Niño; Beatriz Fernandez-Fernandez; Alberto Ortiz
Journal:  Clin Kidney J       Date:  2019-09-28

Review 10.  Inflammatory Targets in Diabetic Nephropathy.

Authors:  Javier Donate-Correa; Desirée Luis-Rodríguez; Ernesto Martín-Núñez; Víctor G Tagua; Carolina Hernández-Carballo; Carla Ferri; Ana Elena Rodríguez-Rodríguez; Carmen Mora-Fernández; Juan F Navarro-González
Journal:  J Clin Med       Date:  2020-02-07       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.